PAINREFORM LTD (PRFX) Stock Overview
USA - NASDAQ:PRFX - IL0011651580 - Common Stock
PRFX Key Statistics, Chart & Performance
The current stock price of PRFX is 1.25 USD. In the past month the price decreased by -18.79%. In the past year, price decreased by -52.58%.
PRFX Latest News, Press Relases and Analysis
PRFX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50.8 | 776.49B | ||
| JNJ | JOHNSON & JOHNSON | 18.48 | 461.88B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 258.77B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.83 | 254.02B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 13.79 | 237.17B | ||
| MRK | MERCK & CO. INC. | 11.34 | 218.03B | ||
| PFE | PFIZER INC | 7.26 | 140.01B | ||
| SNY | SANOFI-ADR | 11.43 | 122.51B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 6.51 | 89.13B | ||
| GSK | GSK PLC-SPON ADR | 9.86 | 88.81B | ||
| ZTS | ZOETIS INC | 23.48 | 64.72B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 50.16 | 44.36B |
Related stock screener links
About PRFX
Company Profile
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Company Info
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442 IL
CEO: Ilan Hadar
Employees: 4
Phone: 97237177051
PAINREFORM LTD / PRFX FAQ
What is the stock price of PAINREFORM LTD today?
The current stock price of PRFX is 1.25 USD. The price increased by 3.31% in the last trading session.
What is the ticker symbol for PAINREFORM LTD stock?
The exchange symbol of PAINREFORM LTD is PRFX and it is listed on the Nasdaq exchange.
On which exchange is PRFX stock listed?
PRFX stock is listed on the Nasdaq exchange.
What is PAINREFORM LTD worth?
PAINREFORM LTD (PRFX) has a market capitalization of 2.51M USD. This makes PRFX a Nano Cap stock.
How many employees does PAINREFORM LTD have?
PAINREFORM LTD (PRFX) currently has 4 employees.
What are the support and resistance levels for PAINREFORM LTD (PRFX) stock?
PAINREFORM LTD (PRFX) has a resistance level at 1.31. Check the full technical report for a detailed analysis of PRFX support and resistance levels.
Should I buy PAINREFORM LTD (PRFX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PRFX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PRFX, evaluating the profitability, health, valuation and growth aspects
- PAINREFORM LTD (PRFX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PAINREFORM LTD (PRFX) Sales and EPS estimates to see what analysts future expectations are.
- PAINREFORM LTD (PRFX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PAINREFORM LTD (PRFX) Insider and Institutional Ownership to learn about the owners and their transactions.
- PAINREFORM LTD (PRFX) Stock Chart to make your own analysis
- PAINREFORM LTD (PRFX) Latest news and press-releases to stay up to date.
Does PAINREFORM LTD (PRFX) stock pay dividends?
PRFX does not pay a dividend.
What is the Price/Earnings (PE) ratio of PAINREFORM LTD (PRFX)?
PAINREFORM LTD (PRFX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-32.16).
What is the Short Interest ratio of PAINREFORM LTD (PRFX) stock?
The outstanding short interest for PAINREFORM LTD (PRFX) is 4.36% of its float. Check the ownership tab for more information on the PRFX short interest.
PRFX Technical Analysis
PRFX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PRFX. While PRFX seems to be doing ok healthwise, there are quite some concerns on its profitability.
PRFX Financial Highlights
Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -32.16. The EPS increased by 81.23% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -322.39% | ||
| ROE | -799.78% | ||
| Debt/Equity | 0 |